This article was originally published in The Tan Sheet
Executive SummaryA new report commissioned by the Project on Emerging Nanotechnologies at the Woodrow Wilson International Center for Scholars stresses the need for regulatory oversight of nanotechnology and provides a "roadmap" for the Environmental Protection Agency to handle the challenges of the science, study author J. Clarence Davies claims. The report presents an agenda to create an "effective oversight system" that includes changing areas within the EPA that deal with science, personnel, international activities and, program integration and evaluation. Released May 23, the 76-page report outlines 25 steps that EPA, the government, the U.S. National Nanotechnology Initiative and industry should take to improve oversight. "This new report seeks to encourage … an intelligent oversight approach that empowers EPA and promotes investment and innovation in new nanotechnology products and processes," PEN Director David Rejeski says...
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.